190 related articles for article (PubMed ID: 35887420)
1. Usefulness of ß-d-Glucan Assay for the First-Line Diagnosis of
Bigot J; Vellaissamy S; Senghor Y; Hennequin C; Guitard J
J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887420
[TBL] [Abstract][Full Text] [Related]
2. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.
Dichtl K; Seybold U; Wagener J
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720434
[TBL] [Abstract][Full Text] [Related]
4. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.
Szvalb AD; Malek AE; Jiang Y; Bhatti MM; Wurster S; Kontoyiannis DP
J Infect; 2020 Sep; 81(3):443-451. PubMed ID: 32650108
[TBL] [Abstract][Full Text] [Related]
5. Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of
Liu L; Yuan M; Shi Y; Su X
Front Cell Infect Microbiol; 2021; 11():784236. PubMed ID: 35004353
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
Del Corpo O; Butler-Laporte G; Sheppard DC; Cheng MP; McDonald EG; Lee TC
Clin Microbiol Infect; 2020 Sep; 26(9):1137-1143. PubMed ID: 32479781
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Giacobbe DR; Dettori S; Di Pilato V; Asperges E; Ball L; Berti E; Blennow O; Bruzzone B; Calvet L; Capra Marzani F; Casabella A; Choudaly S; Dartevel A; De Pascale G; Di Meco G; Fallon M; Galerneau LM; Gallego M; Giacomini M; González Sáez A; Hänsel L; Icardi G; Koehler P; Lagrou K; Lahmer T; Lewis White P; Magnasco L; Marchese A; Marelli C; Marín-Arriaza M; Martin-Loeches I; Mekontso-Dessap A; Mikulska M; Mularoni A; Nordlander A; Poissy J; Russelli G; Signori A; Tascini C; Vaconsin LM; Vargas J; Vena A; Wauters J; Pelosi P; Timsit JF; Bassetti M; ;
Crit Care; 2023 Aug; 27(1):323. PubMed ID: 37620828
[TBL] [Abstract][Full Text] [Related]
8. Is It Possible to Differentiate
Aguilar YA; Rueda ZV; Maya MA; Vera C; Rodiño J; Muskus C; Vélez LA
J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947017
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update.
Lee YT; Chuang ML
J Infect Dev Ctries; 2018 Oct; 12(10):824-834. PubMed ID: 32004150
[TBL] [Abstract][Full Text] [Related]
10. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
[TBL] [Abstract][Full Text] [Related]
11. Study on mNGS Technique in Diagnosing
Li S; Han X; Ma J; Huang GH; Yang ST; Wang CM
Infect Drug Resist; 2024; 17():1397-1405. PubMed ID: 38628239
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
13. Use of β-D-glucan in diagnosis of suspected
Juniper T; Eades CP; Gil E; Fodder H; Quinn K; Morris-Jones S; Gorton RL; Wey EQ; Post FA; Miller RF
Int J STD AIDS; 2021 Oct; 32(11):1074-1077. PubMed ID: 34106017
[TBL] [Abstract][Full Text] [Related]
14. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
15. Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study.
Taniguchi J; Nakashima K; Matsui H; Watari T; Otsuki A; Ito H; Otsuka Y
BMC Infect Dis; 2021 Nov; 21(1):1200. PubMed ID: 34844554
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of Pneumocystis jirovecii in clinical specimens by different methods].
Tekinşen FF; Koç AN
Mikrobiyol Bul; 2013 Oct; 47(4):658-67. PubMed ID: 24237434
[TBL] [Abstract][Full Text] [Related]
17. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.
Matsumura Y; Ito Y; Iinuma Y; Yasuma K; Yamamoto M; Matsushima A; Nagao M; Takakura S; Ichiyama S
Clin Microbiol Infect; 2012 Jun; 18(6):591-7. PubMed ID: 21973089
[TBL] [Abstract][Full Text] [Related]
18. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
[TBL] [Abstract][Full Text] [Related]
19. Point-Counterpoint: Should Serum β-d-Glucan Testing Be Used for the Diagnosis of Pneumocystis jirovecii Pneumonia?
Corsi-Vasquez G; Ostrosky-Zeichner L; Pilkington EF; Sax PE
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31434728
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
Rogina P; Skvarc M
Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
